iSBTc NewsPress ReleaseContact: Tara Withington, CAE (iSBTc Executive Director) NOTE: Members of the media are encouraged to attend the Workshop on "Cancer and Inflammation; Promise for Biological Therapy" free of charge by presenting their press credentials at the iSBTc registration desk. For Immediate Release WORKSHOP TO ADDRESS CANCER AND INFLAMMATION Milwaukee, WI --- The International Society for Biological Therapy of Cancer's (iSBTc) "Workshop on Cancer and Inflammation: Promise for Biological Therapy" (Workshop) will address the double-edged sword of inflammation in regard to cancer, in both promoting and inhibiting tumor formation. Developed by iSBTc and organized by Lisa M. Coussens, PhD, University of California, San Francisco; Steven Dubinett, MD, University of California, Los Angeles; Michael Karin, PhD, University of California, San Diego; Michael T. Lotze, MD, University of Pittsburgh Cancer Institute; and George J. Weiner, MD, University of Iowa, the Workshop will take place in San Diego, CA on Thursday, October 30, 2008 at the Westin Gaslamp Quarter Hotel. The format of the Workshop will promote a scientific discussion about the use of biologic approaches in modifying inflammation and the significant scientific, regulatory and legal issues faced by the various stakeholders in their development and optimized clinical use of biological agents. Workshop attendees will participate in state-of-the-science lectures and breakout sessions on such key issues as:
"The use of immunotherapeutic approaches has been widely considered the best chance for successful eradication of disseminated cancers," said Workshop Organizer, Dr. Michael T. Lotze. "Developing clarity about diagnostic strategies and biomarkers and surrogates to help guide the field and enable both early diagnosis and monitoring during therapy would seem to be critical." With cancer therapies increasingly reliant on agents which modify the inflammatory response, including anti-inflammatory agents such as glucocorticoids and COX2 inhibitors as means of cancer prevention, this interactive Workshop is both timely and of significance to all stakeholders within cancer research. The Workshop proceedings will ultimately be used to formulate a guidance document addressing the use of biological therapies in modifying inflammation. Registration is still open to attend this event. Details and a complete Workshop schedule can be found at iSBTc's website at www.isbtc.org. Founded in 1984, the International Society for Biological Therapy of Cancer is a not-for-profit organization of clinicians, researchers, students, post-doctoral fellows, and allied health professionals dedicated to improving cancer patient outcomes by advancing the development and application of biological therapy through interaction, innovation and leadership. ### |
|
|